Surprisingly, in vitro treatment of PD-1–resistant murine GBM cells with FXIII-A alone also led to increased collagen IV staining similar to that seen in untreated Lair1+/+ GBM tumor–bearing mice. The gene discussed is PDCD1; the disease is glioblastoma.